You are here

Home » CERID Bibliography

CERID Bibliography

Export 42 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antiviral Agents  [Clear All Filters]
2013
Wilkins C, Woodward J, Lau DT-Y, Barnes A, Joyce M, McFarlane N, McKeating JA, D Tyrrell L, Gale M. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology. 2013 ;57(2):461-9.
2012
Jain S, Benoit SR, Skarbinski J, Bramley AM, Finelli L. Influenza-associated pneumonia among hospitalized patients with 2009 pandemic influenza A (H1N1) virus--United States, 2009. Clin Infect Dis. 2012 ;54(9):1221-9.
Bramley AM, Dasgupta S, Skarbinski J, Kamimoto L, Fry AM, Finelli L, Jain S. Intensive care unit patients with 2009 pandemic influenza A (H1N1pdm09) virus infection - United States, 2009. Influenza Other Respir Viruses. 2012 ;6(6):e134-42.
Bedard KM, Wang ML, Proll SC, Loo Y-M, Katze MG, Gale M, Iadonato SP. Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses. J Virol. 2012 ;86(13):7334-44.
Liu HMinyi, Loo Y-M, Horner SM, Zornetzer GA, Katze MG, Gale M. The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe. 2012 ;11(5):528-37.
Johnston C, Saracino M, Kuntz S, Magaret A, Selke S, Huang M-L, Schiffer JT, Koelle DM, Corey L, Wald A. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet. 2012 ;379(9816):641-7.
Polyak SJ, Morishima C, Scott JD, Gastaminza P, Cox A, de Araújo EStanislau, Higgs MR, Loo Y-M, Golden-Mason L, Lindenbach BD, et al. A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 2012 ;142(1):e1-5.
2011
Darwish I, Mubareka S, W Liles C. Immunomodulatory therapy for severe influenza. Expert Rev Anti Infect Ther. 2011 ;9(7):807-22.
Ireton RC, Gale M. RIG-I like receptors in antiviral immunity and therapeutic applications. Viruses. 2011 ;3(6):906-19.
Kay M, Zerr DM, Englund JA, Cadwell BL, Kuypers J, Swenson P, Kwan-Gett TSheng, Bell SL, Duchin JS. Shedding of pandemic (H1N1) 2009 virus among health care personnel, Seattle, Washington, USA. Emerg Infect Dis. 2011 ;17(4):639-44.
2010
Yuan HJ, Jain M, Snow KK, Gale M, Lee WM. Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*. J Viral Hepat. 2010 ;17(3):208-16.
Eide K, Moerdyk-Schauwecker M, Stein DA, Bildfell R, Koelle DM, Jin L. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers. Antivir Ther. 2010 ;15(8):1141-9.
Watson-Jones D, Wald A, Celum C, Lingappa J, Weiss HA, Changalucha J, Baisley K, Tanton C, Hayes RJ, Marshak JO, et al. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials. J Clin Microbiol. 2010 ;48(10):3496-503.
2009
Smith RA, Anderson DJ, Pyrak CL, Preston BD, Gottlieb GS. Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance. J Infect Dis. 2009 ;199(9):1323-6.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009 ;361(20):1935-44.
Daffis S, Suthar MS, Gale M, Diamond MS. Measure and countermeasure: type I IFN (IFN-alpha/beta) antiviral response against West Nile virus. J Innate Immun. 2009 ;1(5):435-45.
Jain MK, Yuan H-J, Adams-Huet B, Reeck A, Shelton J, Attar N, Zhang S, Neumann AU, Carney DS, Gale M, et al. Pegylated interferon and ribavirin promote early evolution of nonstructural 5A protein in individuals with hepatitis C who demonstrate a response to treatment. J Infect Dis. 2009 ;200(6):866-76.
Kwan-Gett TSheng, Baer A, Duchin JS. Spring 2009 H1N1 influenza outbreak in King County, Washington. Disaster Med Public Health Prep. 2009 ;3 Suppl 2:S109-16.
2008
Erickson AK, Seiwert S, Gale M. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection. Antivir Ther. 2008 ;13(7):851-62.
Alpers CE, Smith KD. Cryoglobulinemia and renal disease. Curr Opin Nephrol Hypertens. 2008 ;17(3):243-9.
Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M, Diamond MS. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol. 2008 ;82(17):8465-75.
Chung RT, Gale M, Polyak SJ, Lemon SM, T Liang J, Hoofnagle JH. Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop. Hepatology. 2008 ;47(1):306-20.
Bavaro JB, Drolette L, Koelle DM, Almekinder J, Warren T, Tyring S, Wald A. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection. Sex Transm Dis. 2008 ;35(4):383-6.
2007
Saito T, Hirai R, Loo Y-M, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A. 2007 ;104(2):582-7.
2005
Diaz GA, Rakita RM, Koelle DM. A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2. Clin Infect Dis. 2005 ;40(10):1545-7.

Pages